Clinical Trial Update: A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets [Phase 4]

View source ↗

Summary

A Phase 4 prospective biomarker study in active secondary progressive multiple sclerosis patients treated with cladribine tablets.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cladribine tablets (cladribine)

Snippet

Sponsor: Keith Edwards, M.D. | Conditions: Multiple Sclerosis | Phase 4 | Status: UNKNOWN